Trial NCT04079088

View at ClinicalTrials.gov 
Org. Study IDs: 231MS201
Secondary IDs: 2019-001847-28

Last trial update was posted on 2023-06-01

MeSH Interventions

(T,G)-A-L Glatiramer Acetate Interferon beta-1b Interferon-beta Interferons

MeSH Conditions

Multiple Sclerosis Sclerosis

Other Conditions

Relapsing Multiple Sclerosis

Stopping Reasons

Decision to discontinue BIIB061 program was based on lack of stronger preclinical effects of BIIB061 on remyelination relative to opicinumab, that showed limited clinical efficacy in phase 2 clinical studies. This was not related to safety concerns.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID